Treatment of poliovirus Type I with 10-3 M 2-thiouracil (2-TU) resulted in the inactivation of greater than 90% of the virus infectivity and stabilization of approximately 50% of the residual virus to heat inactivation. These effects were due to a reaction with the protein moiety of the virus and could be blocked by pretreatment of the virus with L-cystine or of the drug with cysteine. Both inactivation and stabilization occurred synchronously and reached equilibrium at the same time. Neither process was reversed by reducing agents. It is suggested that an oxidized form of 2-TU reacts. with capsid sulfhydryl groups to form a product which is stable in either the inactive or heat-resistant form.
The studies of several investigators indicate that the pyrimidine analogue, 2-thiouracil (2-TU), is a potent inhibitor of plant virus replication (for review, see 1) . In the course of recent investigations in this laboratory on the effects of 2-TU on poliovirus replication, it was found that 2-TU reduced the infectivity of poliovirus. Furthermore, that portion of the virus which was not inactivated by high concentrations of 2-TU was partially stabilized to heat inactivation.
The effects of 2-TU bear similarity to those described by others for sulfur compounds (5, 10, 11) . The present report describes the inactivation and heat stabilization of poliovirus infectivity and presents evidence in favor of the hypothesis that an oxidized form of 2-TU reacts with capsid sulfhydryl groups.
MATERIALS AND METHODS
Virus. A plaque-purified strain of Mahoney Type I poliovirus was used throughout these studies. Virus stocks were prepared in bottle cultures of rhesus kidney cells maintained in Eagle's minimal essential medium (MEM) (3) . Later experiments were done with use of virus pools prepared in MEM lacking L-cystine. Virus pools were in general those harvested 8 hr after infection with a multiplicity of 10 plaqueforming units (PFU) per cell. Infected culture fluids were collected and subjected to two cycles of freezing and thawing. After removal of cellular debris by lowspeed centrifugation, the virus stock was stored at -60 C. Virus was used without further purification unless stated otherwise.
When purified virus was used, it was prepared according to a modification of the method of Choppin and Philipson (2) . Briefly, after two cycles of highand low-speed centrifugation in the Spinco model L centrifuge, resuspended pellets were mixed with CsCl to a final density of 1.34 and were centrifuged for 16 to 18 hr at 97,000 X g in a Spinco centrifuge with head SW 39. The virus bands, appearing under a collimated light beam, near the middle of the tube at a CsCl density of 1.34, were harvested and dialyzed against three changes of 1% NaCl for 24 hr prior to storing at -60 C.
Reagents. All reagents (Nutritional Biochemicals Corp., Cleveland, Ohio) were dissolved immediately prior to each experiment. 2-TU was dissolved in 1 N NaOH, diluted to 102 M in distilled water, and adjusted to the required pH with 1 N HCl. The iinary experiments. Inactivation of polio-studies indicated that maximal release of virus fectivity by 2-TU was first observed in occurred at 6 to 7 hr, one possible explanation ents designed to test the effect of this for the supressive effect of drug at 7 hr was the nd on total virus yields. Virus was added inactivation of extracellular virus. Inactivation of iltiplicity of 5 PFU per cell to replicate crude virus was later confirmed and will be dis-'ers, and adsorption was carried out for cussed in detail in the following sections of this ,t 37 C. The monolayers were then washed report. hem from unadsorbed virus and were inIn view of the inactivating effect of 2-TU on at 37 C covered by maintenance medium. poliovirus, studies were not undertaken to deter-,rent times after infection, 2-TU was mine whether this compound was capable of duplicate bottles at a final concentration exerting an inhibitory or mutagenic effect on M. At 7 hr, the total virus yields from poliovirus as has been observed with tobacco Lltures were compared with those from mosaic virus (4, 8) . ich had received buffer in place of 2-TU Effect of 2-TU on virus and infectious RNA. specified time. The average results of four Virus was treated for 2 hr at 37 C with 10 3M 2-)eriments are presented in Fig. 1 . TU in Tris buffer at pH 8. A control consisted of virus treated in the same manner with buffer. After dialysis, one sample of each preparation was titrated for infectivity, and a second was extracted and assayed for infectious RNA. Treatment of virus with 2-TU resulted in a reduction of 90% of the virus infectious titer (Table 1) . However, the yields of infectious RNA from the /*\ inactivated and control preparations were almost identical, representing 0.01% of the initial control virus titer.
In separate experiments, the isolated RNA from the control preparation was treated with 2-TU and with buffer as described above for intact virus. A twofold decrease in infectivity was observed with both treatments. This small amount of inactivation is most likely attributable to trace amounts of contaminating ribonuclease. These findings suggest that 2-TU reacts with the ' on November 2, 2017 by guest http://jvi.asm.org/ Downloaded from periments had been prepared from cells maintained in complete medium containing 25 ,ug of L-cystine per ml which has been shown to be effective in stabilizing poliovirus to thermal inactivation (11) . It seemed likely that stabilization to 2-TU inactivation had occurred as a result of prolonged exposure of the virus to this amino acid after release from the cell.
To determine the effect of L-cystine on viral resistance to drug inactivation, virus was passaged five times in cells maintained in MEM lacking L-cystine, and then was tested for susceptibility to inactivation by heat and 2-TU after treatment for different periods of time with 25 ,ug of L-cystine per ml. Virus which had been grown in the absence of cystine (Fig. 2) was approximately eight times more sensitive (-1.9 log1o survival) to 2-TU inactivation than virus which had been grown in medium containing this compound (-1.0 log1o survival, as seen in Table 1 ). When cystine was added to virus, there was a lag of 0.5 hr, after which resistance to heat and to 2-TU inactivation occurred rapidly, reaching equilibrium at about 6 hr. These results were confirmed in separate experiments when excess cystine was removed by dialysis instead of by dilution, as in this experiment. To obtain reproducible results in the experiments that follow, all virus pools were prepared from cells maintained in medium lacking Lcystine.
Effect of 2-TU concentration. Virus was treated with different concentrations of 2-TU at pH 8 for 2 hr at 37 C, and then assayed for infectivity before and after heating for 5 min at 50 C. Concentrations of 2-TU of 2 X 10-4 M or greater exerted maximal effects in both inactivating and stabilizing the virus (Fig. 3) . Almost 99% of the virus was inactivated, but most of the residual infectious virus was heat-resistant. When diluted below 5 X 10r M, the drug exerted no noticeable effect. Similar findings were obtained in experiments with purified virus.
Egffect of pH on inactivation. The effect of pH on the kinetics of inactivation was studied by treating virus with 10-3 M 2-TU over a pH range of 6 to 9 for 5, 30, and 120 min (Fig. 4) .
At pH 7 and below, virus was inactivated rapidly, reaching equilibrium levels of survival after 5 min, whereas, above pH 7, the rate of inactivation was slower and apparently dependent on pH. However, the ultimate extent of inactiva- Figure 5 shows the results of such an experiment. The sample of 2-TU obtained after 90 min of exposure to air caused 98% inactivation and stabilization to heat of 83% of the residual infectious virus. Further aeration of the drug did not appreciably increase either effect.
Although it was possible to show that inactivation and heat stabilization at alkaline pH were dependent on aeration of 2-TU solutions, attempts to show the presence of an oxidized form of 2-TU by measurement of the total absorption spectrum of 2-TU solutions which had been aerated for up to 24 hr were unsuccessful. These results indicate that the proportion of oxidized 2-TU is insufficient for detection by UV absorption.
Kinetics of heat inactivation. Virus which had been treated with 10-3 M 2-TU for 2 hr was heated for different periods of time at 50 C. The results presented in Fig. 6 indicate that approxi- (Table 2) . When the amount of cysteine was reduced 10-fold, no protective effect of cysteine was noticeable. The protective effect of cysteine at the higher concentration was not due to a stabilizing effect on the virus, for virus pretreated with cysteine was as susceptible to 2-TU inactivation as untreated virus.
Attempts to reverse inactivation and stabilization. Although it was possible in the preceding experiment to reduce the inactivating effect of 2-TU with cysteine, it was not possible to reverse 
DIscussIoN
A number of sulfur compounds have been found both to inactivate poliovirus and to confer on the virus a resistance to inactivation by heat (5) . The effects of 2-TU are in many ways analogous to those of other compounds, but they differ in that they are not reversed by sulfhydrylcontaining compounds, even when the latter are present in concentrations 100 times that of 2-TU.
Philipson and Choppin (10) found that inactivation of enteroviruses by 2,3-dimercaptopropanol (BAL) was attributable to an oxidized form of this compound. Activation of BAL was dependent on exposure to air, and they suggested that a disulfide of BAL took part in an interchange with sulfhydryl groups of the virus capsid. A similar mechanism may be active in our system, but, if so, the proportion of disulfide in the active reagent was too small to give a detectable absorption peak against the background of absorption by the reduced compound. Analogy to the cysteine-cystine system studied by Pohjanpelto (11) suggests that such a large excess of reduced compound would shift the equilibrium away from the combined product. The fact that this was not the case indicates caution in assuming that the disulfide of 2-TU is the active form of this drug. If it is, then one must suppose that the virus-2-TU product is stabilized by secondary bonds not found with cystine, Na2$4, or oxidized BAL.
Oxidation of 2-TU as carried out with iodine may easily proceed beyond the disulfide (9), presumably yielding a sulfonic acid derivative. The reactions of this compound are unexplored, but other sulfonates react with thiol groups (12) .
The possibility cannot be ignored that the reaction in the 2-TU-poliovirus system is between virus sulfhydryl groups and a sulfonate of uracil.
Whatever the precise nature of the active form of the drug, it seems probable that the reactive site on the virus is a protein sulfhydryl group. This is suggested by the finding that prior treatment of virus with cystine, which would convert the sulfhydryls to disulfides, reduces the capability of the virus to react with 2-TU. No virus substituent other than the capsid sulfhydryl presents itself as a logical site for this action. This is further corroborated by the similarity of stabilization to heat inactivation by L-cystine and by The pH optimum below 7 found in this study also differs from that reported for reactions of enteroviruses with disulfide compounds. One would expect that reactivity of the disulfide derivative of 2-TU would be enhanced by high pH, but the oxidation of 2-TU to its active form may be the rate-limiting step here, not the reaction of drug with virus.
The similarity of the curves for the inactivation reaction and for the stabilization suggests a common rate-limiting step. This might again be the rate of drug oxidation or it might be the rate of successful contact with a common site on the virus. Stabilization does not appear to be an intermediate step in the path to inactivation, because both processes start synchronously and reach equilibrium at the same time. Rather, the reactions appear to be competitive, and that proportion of the virus which is stabilized against heat may also be protected against inactivation by 2-TU. The outcome for any virus particle may depend on which of two stearic configurations of the virus or which of two mutually competing sites on the virus capsid react first. Alternatively, it may be a question of which of two forms of the drug react first, provided that both reactions are stable and mutually exclusive.
